PIPages
Labs

Steffani Bailey

Oregon Health & Science University, OR·Public Health & Epidemiology

Treatments for addiction work, but they only help people who can actually reach them. Only about one in four U.S.

Fields

Public Health & Epidemiology

Medicine & Clinical Research

Social Science

Topics

opioid use disorder

buprenorphine

telehealth

Grants
3 known grants, through Mar 2030

What they work on

  1. Examine rates of opioid use disorder care — diagnosis, buprenorphine and other medication orders, retention on medication, and behavioral health visits — before, during, and after telehealth expansion, using nearly a decade of OCHIN electronic health record data from community health centers in 35 states.
  2. Compare opioid use disorder care across visit modality (in-person, video, telephone) over time, and identify patient- and community-level factors, such as rural residence or age, that moderate how modality relates to receiving and staying on medication.
  3. Test whether Oregon's 2017 Medicaid policy requiring smoking cessation before elective surgery changed cessation assistance, quit rates, rates of surgery received, and surgical complications, by linking community health center records to Medicaid claims in a pre/post quasi-experimental design.
  4. Explore how clinics implemented the pre-surgery cessation policy and its intended and unintended consequences, through semi-structured interviews with health system leaders, primary care clinicians, orthopedic surgeons, and patients, plus surveys of Coordinated Care Organization leaders.
  5. Determine, in a cluster-randomized trial of 30 Oregon community health centers and about 15,000 patients who smoke, whether adding enhanced academic detailing to a bidirectional Quitline electronic referral system increases the reach and effectiveness of cessation assistance.
  6. Evaluate the cost-effectiveness of the Quitline electronic referral system with and without enhanced academic detailing, using electronic health record and Quitline outcome data.

More about the research

adults with opioid use disorder receives medication for it, and smoking remains far more common among low-income, Medicaid-insured, and uninsured adults than in the general population. These projects study how health policies and clinic workflows change whether patients get that care, using community health centers — safety-net clinics serving largely uninsured and publicly insured patients — as the setting. The common thread is large-scale electronic health record data, policy changes used as natural experiments, and trials of practical ways to deliver treatment, with attention to whether changes close gaps between patient groups or widen them.

Why it matters

Together these studies tell policymakers and clinics what actually helps underserved patients get treatment. OUTREACH findings are intended to inform federal, state, and local telehealth rules and clinical guidelines for opioid use disorder, and to show whether extra supports are needed so that phone or video care does not leave rural and older patients behind. ASSIST gives states evidence on whether pre-surgery quit requirements help Medicaid patients stop smoking or block access to surgery. CONNECT could offer a scalable, costed way for safety-net clinics to link low-income smokers to effective cessation help.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

OUTREACH: Opioid Use TReatment via telehEAlth in CHCs

NIH · Jul 2025 – Mar 2030

ASSIST: Assessment of Medicaid policy on Smoking Cessation Assistance and Surgical Outcomes

NIH · Sep 2023 – May 2028

CONNECT: COmpreheNsive traiNing and Engagement in Cessation Treatment

NIH · Jul 2021 – Feb 2027

Closest labs

Kathryn Taylor

Georgetown University, DC·Public Health & Epidemiology

Compare electronic quitline referral against a centralized health-system phone counseling plus nicotine replacement program for lung screening patients, measuring biologically verified quitting at 3 and 6 months.

Nicole Kelly

University of California-San Diego, CA·Public Health & Epidemiology·Early-career

Evaluate how North Carolina's Medicaid expansion affected use of long-acting injectable HIV therapy (LAI-ART) and opioid use disorder medication (LAI-MOUD) among people with both conditions, using quasi-experimental policy evaluation methods.

Barbara Andraka-Christou

University of Central Florida, FL·Public Health & Epidemiology

Build a public, year-by-year database of state statutes, regulations and executive orders (2014–2024) meant to promote medications for opioid use disorder after ED overdose visits, using expert-guided searches of NexisUni legal software.

The school

Oregon Health & Science University: 24 labs on PI Pages, $545M a year on research, 54 research doctorates a year.

More about Oregon Health & Science University

Reach out

A start for your email. Fill in the brackets.